drugset / Trial / NCT01202409

CAPOX in KRAS Wild-Type Advanced Adenocarcinoma of the Small Bowel or Ampulla of Vater

NCT01202409 ↗

Phase 2 Completed 19 enrolled M.D. Anderson Cancer Center Amgen · collab
NaSingle-groupOpen-labelTreatment

Summary

The goal of this clinical research study is to learn if panitumumab can help to control advanced cancer of the small bowel or ampulla of Vater. The safety of this drug will also be studied.

Timeline

Start
2010-11-02
Primary completion
2018-07-03
Completion
2018-07-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Panitumumab Monoclonal antibody 9 mg/kg Intravenous